One in three babies born in 2013 are expected to live until they are 100. This is a projection from the Office for National Statistics.
Although life expectancy in the United States for 2017 is set at 79.13 years, that’s pretty high compared to countries like Liberia with a life expectancy of 59.4 years.
We may have the science and research community to thank for the ever-increasing life expectancy on this planet. According to a study published November 30, 2015, Metformin (packaged as Glucophage XR) is the world’s first anti-aging drug that could allow people to live healthily into their 120’s.
“If you target an aging process and you slow down aging, then you slow down all the diseases and pathology of aging as well,” said aging expert Prof Gordon Lithgow, of the Buck Institute for Research on Aging in California, and one of the study advisers.
“That’s revolutionary. That’s never happened before. The future is taking the biology that we’ve now developed and applying it to humans.”
Researchers have proven that the diabetes drug, Metformin (Glucophage XR) extends the life of animals. Now experts want to see if these effects can be replicated in humans.
Belgian researchers discovered that when roundworms were given metformin, they aged slower and stayed healthier longer.
Further studies revealed that metformin (Glucophage XR) reduces the risk of cardiovascular disease and cancer. Scientists hope that someday it will prevent the debilitating diseases of old age.
Trials have begun on a group of 3,000 70 to 80-year-olds who have or are at risk of cancer, heart disease and dementia. This is a 5-7-year trial to assess the drug’s ability to attack the process of aging, rather than individual diseases.
Nir Barzilai, of the American Federation for Aging Research, said: “We are confident that once the FDA becomes open to aging as an indication, more and better drugs will be rapidly developed.
“We believe that there is a great benefit for healthy lifespan, not only to the individual, but also for society in the form of cost savings, which is often referred to as the longevity dividend.”
He added: “If indeed metformin is a drug that can target the aging process, its administration should be associated with less age-related disease in general, rather than the decreased incidence of a single age-related disease.”
Those who desire longevity desire it along with the understanding that they will enjoy a quality of life to make life worth living.
Metformin (Glucophage XR) is the world’s most widely used diabetes drug. For more than 60 years it has had widespread use safely and with very few side effects when used as directed.
Glucophage XR reduces oxidative stress and inflammation. It decreases the amount of sugar that the liver produces and the intestines absorb. Glucophage XR also causes the body to be more sensitive to its own insulin.